| Primary |
| Lymphoma |
25.8% |
| Acute Leukaemia |
14.0% |
| Malignant Melanoma |
12.9% |
| Antibiotic Therapy |
6.5% |
| Glioma |
5.4% |
| Hodgkin's Disease Stage Iii |
5.4% |
| Mycosis Fungoides |
5.4% |
| Urinary Tract Infection |
4.3% |
| Central Nervous System Lymphoma |
3.2% |
| T-cell Lymphoma |
3.2% |
| Glioblastoma |
2.2% |
| Premedication |
2.2% |
| Psoriasis |
2.2% |
| Bone Graft |
1.1% |
| Bone Marrow Transplant |
1.1% |
| Brain Neoplasm |
1.1% |
| Diarrhoea |
1.1% |
| Dyslipidaemia |
1.1% |
| Gastritis |
1.1% |
| Hodgkin's Disease |
1.1% |
|
| Incorrect Storage Of Drug |
12.8% |
| Circumstance Or Information Capable Of Leading To Medication Error |
10.3% |
| Oral Discomfort |
10.3% |
| Pneumonitis |
10.3% |
| Thrombocytopenia |
10.3% |
| Haemolytic Anaemia |
5.1% |
| Pleural Fibrosis |
5.1% |
| Syncope |
5.1% |
| Acute Myeloid Leukaemia |
2.6% |
| Acute Pulmonary Oedema |
2.6% |
| Adverse Event |
2.6% |
| Altered State Of Consciousness |
2.6% |
| Blood Pressure Increased |
2.6% |
| Burning Sensation |
2.6% |
| Cardiac Disorder |
2.6% |
| Colitis Ischaemic |
2.6% |
| Cough |
2.6% |
| Cytomegalovirus Infection |
2.6% |
| Death |
2.6% |
| Dyspnoea |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.5% |
| Lymphoma |
13.1% |
| Mantle Cell Lymphoma |
11.6% |
| B-cell Lymphoma |
11.2% |
| Diffuse Large B-cell Lymphoma |
7.4% |
| Product Used For Unknown Indication |
5.9% |
| Multiple Myeloma |
5.1% |
| Hyperthermia |
5.0% |
| Bone Marrow Transplant |
4.6% |
| Non-hodgkin's Lymphoma |
3.8% |
| Urinary Tract Infection |
2.1% |
| Glioma |
1.9% |
| Transplant |
1.9% |
| Plasma Cell Myeloma |
1.7% |
| Hodgkin's Disease Nodular Sclerosis Stage Ii |
1.5% |
| Central Nervous System Lymphoma |
1.0% |
| Nausea |
1.0% |
| Premedication |
1.0% |
| Prophylaxis |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
|
| Acute Myeloid Leukaemia |
10.5% |
| Pancytopenia |
8.8% |
| Pulmonary Fibrosis |
8.8% |
| Agranulocytosis |
5.3% |
| Death |
5.3% |
| Eyelid Ptosis |
5.3% |
| Myelofibrosis |
5.3% |
| Refractory Anaemia With An Excess Of Blasts |
5.3% |
| Renal Failure Acute |
5.3% |
| Respiratory Failure |
5.3% |
| Urinary Tract Infection |
5.3% |
| Haemolytic Anaemia |
3.5% |
| Myelodysplastic Syndrome |
3.5% |
| Necrotising Fasciitis |
3.5% |
| Pyrexia |
3.5% |
| Sepsis |
3.5% |
| Stomatitis |
3.5% |
| Thrombocytopenia |
3.5% |
| Toxic Skin Eruption |
3.5% |
| Bone Marrow Failure |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.9% |
| Drug Use For Unknown Indication |
22.5% |
| B-cell Lymphoma |
16.0% |
| Diffuse Large B-cell Lymphoma |
7.0% |
| Premedication |
3.3% |
| Chemotherapy |
2.8% |
| Infection Prophylaxis |
2.8% |
| Cardiac Failure |
1.9% |
| Lung Disorder |
1.9% |
| T-cell Lymphoma |
1.9% |
| Bone Marrow Conditioning Regimen |
1.4% |
| Febrile Bone Marrow Aplasia |
1.4% |
| Glioblastoma |
1.4% |
| Cytapheresis |
0.9% |
| Dyslipidaemia |
0.9% |
| Prophylaxis |
0.9% |
| Glioblastoma Multiforme |
0.5% |
| Lymphoma |
0.5% |
|
| Cholestasis |
11.1% |
| Osteonecrosis |
11.1% |
| Cardio-respiratory Arrest |
7.4% |
| Electrocardiogram Qt Prolonged |
7.4% |
| Pancytopenia |
7.4% |
| Thrombosis |
7.4% |
| Acute Graft Versus Host Disease |
3.7% |
| Agranulocytosis |
3.7% |
| Bronchopulmonary Aspergillosis |
3.7% |
| Hepatitis Cholestatic |
3.7% |
| Ileus Paralytic |
3.7% |
| Lung Disorder |
3.7% |
| Meningism |
3.7% |
| Renal Failure |
3.7% |
| Stem Cell Transplant |
3.7% |
| Surgery |
3.7% |
| Urinary Tract Infection |
3.7% |
| Venoocclusive Liver Disease |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
|
